Health care organizations are using clinical data to respond to the potential impact of the One Big Beautiful Bill Act on their operations, finances and patient care delivery.
"It's no surprise that clinical data is at the center of preparedness," said Eric Crites, senior vice president of enterprise partnerships at Q-Centrix. "Clinical data has always held immense value, and in a constantly evolving environment, it remains the industry's most reliable source of truth -- helping leaders cut through uncertainty, test strategies and make decisions grounded in reality."
Nearly three-fourths of respondents to a recent survey by the data management company voiced concern about how the act might affect their organization. Rural hospitals expressed the highest level of alarm at 80%. More than half of these rural hospital leaders cited facility closures as their top fear. For non-rural hospitals, the top worries were care delays (45%) and loss of Medicaid revenue (42%), while life sciences organizations pointed to financial strain (63%) and potential shifts in research and development strategy (63%).
"This is more than just policy talk -- it's the kind of change that could disrupt the entire health care ecosystem," Crites said. “The survey results highlight both the urgency and the uneven levels of preparedness across the industry."
Only half of respondents feel ready to manage the legislation’s potential effects. Payers are the most prepared (66%), with some starting planning efforts more than a year ago. Non-rural hospitals lag far behind, with just 43% feeling prepared and only 5% having started early planning. In other findings:
- Three-fourths believe the One Big Beautiful Bill At will affect their organization. Payers are most likely to anticipate a major impact at 58%.
- Payers lead in early planning, One-fourth started more than a year ago, compared with 5% of non-rural hospitals.
- Fifty-seven percent are planning changes in response; payers lead at 75%, while rural hospitals trail (40%).
As a result, most respondents see clinical data as a critical tool for navigating the changes ahead, with 81% saying their organization plans to use it to inform or assess any changes under consideration.
“As debate over the bill's impact on health care continues, this survey -- along with consumer perspectives on tariff effects -- highlights a crucial point,” the survey report concluded. “Most health care leaders anticipate significant challenges in the days ahead, with care delays, financial strain and even facility closures at the top of their concerns.”
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.